Ely Benaim
No más puestos en curso
Fortuna: 449 675 $ al 31/03/2024
Perfil
Ely Benaim es director médico de NovoCure Ltd. En el pasado, el Dr. Benaim ocupó el cargo de Vicepresidente de Asuntos Clínicos en Sangamo Therapeutics, Inc., Director Médico y Vicepresidente Senior de Asuntos Regulatorios en Berg Pharma LLC, Director Senior de Investigación Clínica en Millennium Pharmaceuticals, Inc., Director Médico de Rexahn Pharmaceuticals, Inc. y Director Senior de Oncología Global en Salmedix, Inc. y Profesor Asistente en la Universidad de Tennessee. El Dr. Benaim se doctoró en la Universidad Central de Venezuela.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NOVOCURE LTD.
0.03% | 06/01/2023 | 28 770 ( 0.03% ) | 449 675 $ | 31/03/2024 |
Antiguos cargos conocidos de Ely Benaim.
| Empresas | Cargo | Fin |
|---|---|---|
| NOVOCURE LIMITED | Chief Tech/Sci/R&D Officer | 17/01/2023 |
| REXAHN PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/03/2019 |
| Berg Pharma LLC | Chief Tech/Sci/R&D Officer | 01/01/2015 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2010 |
Formación de Ely Benaim.
| Central University of Venezuela | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Empresas privadas | 4 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
| Berg Pharma LLC |
- Bolsa de valores
- Insiders
- Ely Benaim
